Overview

Childhood skin diseases are associated with severe burden on patients, families, and health care providers. Despite this burden, effective treatments are sparse, the pace of research is slow, and board-certified pediatric dermatologists remain few-in-number. Furthermore, mid-career clinician scientists in the field often encounter challenges after receiving early career start up funds from their institution, traditional career development awards, or small pilot grants, which may contribute to stress, increased prioritization of clinic work over research, and high rates of burnout.

To better support the full career trajectory of clinician scientists in the field, the Pediatric Dermatology Research Alliance (PeDRA) is offering the Career Bridge Research Grant to support one mid-career investigator in the conduct of an innovative research study in the field of pediatric dermatology. Applications may be submitted by a pediatric dermatologist between seven and fifteen years out of training for $80,000 to support salary and research activities for two years.

Goals

The Career Bridge Research Grant is driven by PeDRA’s commitment to support both research and researchers in the field of pediatric dermatology. It is intended to provide protected research time and resources for a mid-career clinician scientist conducting high-impact research in the field.

Priority consideration will be given to mid-career investigators collaborating with senior mentors, projects that address high-priority patient-centered research questions, and projects that align with the focus of any of PeDRA’s Focused Study Groups.

Important Details

• $80,000 to support salary and research activities over two years for mid-career pediatric dermatologists
• Priority consideration to mid-career investigators collaborating with senior mentors, projects that address high-priority patient-centered research questions, and projects that align with the focus of any of PeDRA’s Focused Study Groups
• Application deadline was 11:59 PM PT on Thursday, December 4, 2025